EP Biocomposites Ltd
₹ 106
13.24%
26 Nov
- close price
About
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
Key Points
- Market Cap ₹ 17.9 Cr.
- Current Price ₹ 106
- High / Low ₹ 230 / 90.5
- Stock P/E 19.5
- Book Value ₹ 63.5
- Dividend Yield 0.00 %
- ROCE 14.3 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.4% over last 3 years.
- Company has high debtors of 330 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | 11.67 | |
| 0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | 10.13 | |
| Operating Profit | 0.04 | 0.46 | 1.40 | 0.97 | 1.41 | 1.78 | 1.54 |
| OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.82% | 13.20% |
| 0.00 | 0.00 | 0.02 | 0.17 | 0.30 | 0.11 | 0.13 | |
| Interest | 0.00 | 0.00 | 0.19 | 0.23 | 0.04 | 0.36 | 0.34 |
| Depreciation | 0.00 | 0.00 | 0.07 | 0.10 | 0.10 | 0.11 | 0.11 |
| Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 | 1.22 |
| Tax % | 25.00% | 23.91% | 31.03% | 28.40% | 26.75% | 27.46% | |
| 0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | 0.92 | |
| EPS in Rs | 6.00 | 72.00 | 6.88 | 3.45 | 6.84 | 6.13 | 5.48 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 84% |
| 3 Years: | 14% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 103% |
| 3 Years: | 8% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 11% |
| Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 | 1.68 |
| Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 | 9.00 |
| 0.00 | 0.00 | 4.11 | 1.28 | 1.80 | 2.98 | 3.69 | |
| 0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | 1.43 | |
| Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 15.80 |
| 0.00 | 0.00 | 0.41 | 0.33 | 0.33 | 0.23 | 0.20 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.14 | 0.15 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | 15.45 | |
| Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 | 15.80 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | |
| 0.00 | 0.00 | -0.47 | 0.02 | -0.16 | 0.02 | |
| 0.00 | 0.00 | 4.76 | 2.81 | 0.49 | 0.82 | |
| Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 192.11 | 80.42 | 321.53 | 300.41 | 287.40 | 330.05 |
| Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 |
| Days Payable | 349.79 | 128.35 | 161.90 | 104.79 | 143.08 | 97.87 |
| Cash Conversion Cycle | -74.04 | 42.32 | 246.47 | 286.20 | 194.45 | 298.85 |
| Working Capital Days | -57.63 | 25.98 | 156.69 | 255.81 | 217.47 | 270.79 |
| ROCE % | 219.05% | 41.54% | 13.16% | 15.30% | 14.28% |
Documents
Announcements
-
Financial Results For The Half Year Ended September 30, 2025
3 Nov - Board approved unaudited H1 results to Sept 30, 2025: revenue Rs407.48L, PAT Rs9.04L, EPS Rs0.54.
-
Board Meeting Outcome for Outcome Of The Board Meeting- Financial Results For The Half Year Ended September 30, 2025
3 Nov - Unaudited H1 FY2025 results: Revenue Rs.407.48L, PAT Rs.9.04L, EPS 0.54; approved Nov 3, 2025.
-
Board Meeting Intimation for Consideration Of The Financial Results For The Half Year Ended September 30, 2025
30 Oct - Board meeting Nov 3, 2025 at 4:00 PM to approve draft financial results for half-year ended Sept 30, 2025.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
3 Oct - EP Biocomposites AGM Sept 30, 2025: audited financials adopted; three director appointments/reappointments; related-party industrial plot purchase approved.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 30 Sep
Business Overview:[1]
a) EPBL is a flagship entity of EP Kamat
Group.
b) It manufactures and supplies Fibre
Reinforced Polymers (FRP) products
such as Door Shutters, Frames, Laminated
Doors, Biodigester Tanks, Bio Toilets and
Allied Products for Construction and Industrial applications
c) Company has an Aqua Division which offers Sewage & Effluent Treatment Plants for Hotels, Industry, Institutions, Government bodies as well as residential and commercial buildings
d) In FY24, company has added the line
of Fire doors to its portfolio